BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21460204)

  • 1. EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.
    Macedo C; Webber SA; Donnenberg AD; Popescu I; Hua Y; Green M; Rowe D; Smith L; Brooks MM; Metes D
    J Immunol; 2011 May; 186(10):5854-62. PubMed ID: 21460204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients.
    Macedo C; Zeevi A; Bentlejewski C; Popescu I; Green M; Rowe D; Smith L; Webber S; Metes D
    Transplantation; 2009 Jul; 88(1):123-8. PubMed ID: 19584691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
    Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
    Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Gotoh K; Ito Y; Ohta R; Iwata S; Nishiyama Y; Nakamura T; Kaneko K; Kiuchi T; Ando H; Kimura H
    J Infect Dis; 2010 Aug; 202(3):461-9. PubMed ID: 20560768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
    Sebelin-Wulf K; Nguyen TD; Oertel S; Papp-Vary M; Trappe RU; Schulzki A; Pezzutto A; Riess H; Subklewe M
    Transpl Immunol; 2007 Apr; 17(3):203-10. PubMed ID: 17331848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.
    Cárdenas Sierra D; Vélez Colmenares G; Orfao de Matos A; Fiorentino Gómez S; Quijano Gómez SM
    Clin Exp Immunol; 2014 Jul; 177(1):320-32. PubMed ID: 24666437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
    Ning RJ; Xu XQ; Chan KH; Chiang AK
    Immunology; 2011 Oct; 134(2):161-71. PubMed ID: 21896011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
    Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.
    Calarota SA; Chiesa A; Zelini P; Comolli G; Minoli L; Baldanti F
    Immunology; 2013 Aug; 139(4):533-44. PubMed ID: 23560877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38
    Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.
    Falco DA; Nepomuceno RR; Krams SM; Lee PP; Davis MM; Salvatierra O; Alexander SR; Esquivel CO; Cox KL; Frankel LR; Martinez OM
    Transplantation; 2002 Aug; 74(4):501-10. PubMed ID: 12352909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.
    Torre-Cisneros J; Román J; Torres A; Herrera C; Caston JJ; Rivero A; Mingot E; Rojas R; Martín C; Martínez F; Gómez P
    J Infect Dis; 2004 Nov; 190(9):1596-9. PubMed ID: 15478063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.
    Marshall NA; Howe JG; Formica R; Krause D; Wagner JE; Berliner N; Crouch J; Pilip I; Cooper D; Blazar BR; Seropian S; Pamer EG
    Blood; 2000 Oct; 96(8):2814-21. PubMed ID: 11023516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Macedo C; Donnenberg A; Popescu I; Reyes J; Abu-Elmagd K; Shapiro R; Zeevi A; Fung JJ; Storkus WJ; Metes D
    Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional diversity of the CD8(+) T-cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders.
    Nazaruk RA; Rochford R; Hobbs MV; Cannon MJ
    Blood; 1998 May; 91(10):3875-83. PubMed ID: 9573025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
    Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
    J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
    Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
    J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study.
    Baudouin V; Dehée A; Pédron-Grossetete B; Ansart-Pirenne H; Haddad E; Maisin A; Loirat C; Sterkers G
    Transplantation; 2004 Jun; 77(11):1706-13. PubMed ID: 15201670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Yoshimi A; Tsuge I; Namizaki H; Hoshino Y; Kimura H; Takahashi Y; Watanabe N; Kuzushima K; Kojima S
    Br J Haematol; 2002 Mar; 116(3):710-5. PubMed ID: 11849237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.